{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:09:09Z","timestamp":1784038149932,"version":"3.55.0"},"reference-count":22,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<title>ABSTRACT<\/title>\n                  <sec>\n                    <title>Objective.<\/title>\n                    <p>This analysis aimed to identify the underlying causes of gaps in routine immunization coverage observed during the COVID-19 pandemic recovery phase by applying the open-source Vaccination Coverage Quality Indicators package in R (vcqiR), addressing limitations in Multiple Indicator Cluster Surveys (MICS) that often omit quality metrics based on detailed vaccination date analysis.<\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Methods.<\/title>\n                    <p>This secondary analysis examined vaccination doses and dates from the Jamaica 2022 MICS (MICS4), for 570 children ages 12\u201323 months and 24\u201335 months. Specific indicators included coverage, timeliness, dropouts, and missed opportunities for simultaneous vaccinations (MOSVs).<\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Results.<\/title>\n                    <p>Vaccination coverage for first-year-of-life (1YL) doses exceeded 83% for both age cohorts. Coverage for MMR1 showed substantial catch-up from 12\u201323 months to 24\u201335 months, achieving the 95% target. However, MMR2 coverage lagged substantially (37.2% for 12\u201323 months and 61.9% for 24\u201335 months), indicating significant attrition in the second year of life. In the 12\u201323 month cohort, crude coverage of Penta3 was 89%, but only 70% had three valid doses. Most 1YL doses were administered in a timely manner (within 28 days), but premature administration was observed. MOSVs were negligible for 1YL doses but were frequent and mostly uncorrected for 18-month boosters, especially MMR2.<\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Conclusions.<\/title>\n                    <p>The findings complement the MICS4 report and confirm robust early infant immunization delivery but identify programmatic gaps in second year-of-life retention plus the need to strengthen adherence to minimum age interval rules. These results provide detailed evidence necessary to inform targeted interventions and guide the design of future coverage surveys.<\/p>\n                  <\/sec>","DOI":"10.26633\/rpsp.2026.49","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:49:26Z","timestamp":1784036966000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Assessing vaccination coverage quality in Jamaica during COVID-19 using vcqiR: insights from the 2022 MICS"],"prefix":"10.26633","volume":"50","author":[{"given":"Anya","family":"Cushnie","sequence":"first","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-3447-9710"},{"name":"Pan American Health Organization, Kingston, Jamaica."},{"name":"cushnieany@paho.org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale A.","family":"Rhoda","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-0948-1368"},{"name":"Biostat Global Consulting, Worthington, Ohio, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin B.","family":"Clary","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0001-7283-749X"},{"name":"Biostat Global Consulting, Worthington, Ohio, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Brustrom","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0002-5865-3595"},{"name":"Biostat Global Consulting, Worthington, Ohio, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kay","family":"Trimner","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-3591-1579"},{"name":"Biostat Global Consulting, Worthington, Ohio, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bertacchini","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-2651-8935"},{"name":"Pan American Health Organization, Kingston, Jamaica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ojeda","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0009-0008-3645-0835"},{"name":"Pan American Health Organization, Comprehensive Immunization Program, Washington, DC, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Velandia-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0002-7636-3604"},{"name":"Pan American Health Organization, Comprehensive Immunization Program, Washington, DC, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Shattock AJ, Johnson HC, Sim SY, Carter A, Lambach P, Hutubessy RC, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet. 2024;403(10441):2307\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(24)00850-X","DOI":"10.1016\/S0140-6736(24)00850-X"},{"key":"ref2","unstructured":"World Health Organization (WHO). Immunization coverage: global progress and challenges in 2022 (Internet). Geneva: WHO; 2023 (cited 2025 Nov 3). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Basu S, Ashok G, Debroy R, Ramaiah S, Livingstone P, Anbarasu A. Impact of the COVID-19 pandemic on routine vaccine landscape: a global perspective. Hum Vaccines Immunother. 19(1):2199656. https:\/\/doi.org\/10.1080\/21645515.2023.2199656","DOI":"10.1080\/21645515.2023.2199656"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Rombini MF, Mauas RP, Katz N, Urue\u00f1a A. Ranking of immunization programs in Latin America, 2020 [Ranking dos programas de vacina\u00e7\u00e3o na Am\u00e9rica Latina, 2020]. Rev Panam Salud Publica Pan Am J Public Health. 2024;48:e15. https:\/\/doi.org\/10.26633\/RPSP.2024.15","DOI":"10.26633\/RPSP.2024.15"},{"key":"ref5","unstructured":"World Health Organization (WHO), United Nations Children\u2019s Fund (UNICEF). Jamaica: WHO and UNICEF estimates of immunization coverage: 2023 revision (Internet). Geneva: WHO; 2024 (cited 2025 Nov 20). Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/immunization\/2024-country-profiles\/immunization-2024-jam.pdf?sfvrsn=7c180b9f_3&download=true"},{"key":"ref6","unstructured":"Ministry of Health and Wellness, Jamaica. Jamaica population health status report, 2000-2022 (Internet); Kingston: Ministry of Health and Wellness; 2024. Available from: https:\/\/www.moh.gov.jm\/wp-content\/uploads\/2024\/05\/Jamaica-Population-Health-Status-Report-2000-2022.pdf"},{"key":"ref7","unstructured":"Ministry of Health and Wellness, Jamaica. Expanded Programme on Immunization (EPI) Self-Assessment Report 2025. Kingston: Ministry of Health and Wellness; 2025."},{"key":"ref8","unstructured":"Government of Jamaica. The Public Health Act Regulations (under section 14), The Public Health (Immunization) Regulations, 1986. Kingston, Government of Jamaica; 1986."},{"key":"ref9","unstructured":"Planning Institute of Jamaica. Jamaica Multiple Indicator Cluster Survey 2022 (Internet). Kingston: Planning Institute of Jamaica; 2024. Available from: https:\/\/mics.unicef.org\/download-tracker\/38206\/8516"},{"key":"ref10","unstructured":"Ministry of Health and Wellness, Jamaica. Jamaica\u2019s immunization schedule. Kingston: Ministry of Health and Wellness (Internet); 2024 (cited 2025 Nov 3). Available from: https:\/\/vaccination.moh.gov.jm\/"},{"key":"ref11","unstructured":"Rhoda DA, Clary CB, Yu M. Getting started with VCQI for R users, draft version 1.0; 2022. 21 p."},{"key":"ref12","unstructured":"Rhoda DA, Prier ML, Trimner MK. VCQI forms and variable list (FVL) document, draft version 1.7 (Internet). Biostat Global Consulting; 2021 (cited 2021 May 26). Available from: http:\/\/www.biostatglobal.com\/downloads\/VCQI%20Forms%20and%20Variable%20List%20(FVL)%20Document.pdf"},{"key":"ref13","unstructured":"United Nations Children\u2019s Fund (UNICEF). UNICEF MICS (Internet); 2025 (cited 2025 Oct 22). Available from: https:\/\/mics.unicef.org\/"},{"key":"ref14","unstructured":"Blinded T. GitHub repository to accompany Jamaica MICS 2022 VCQI manuscript (Internet). (cited 2025 Dec 3). Available from: https:\/\/github.com\/anonyrepo-web\/jamaica_analysis"},{"key":"ref15","unstructured":"World Health Organization (WHO), United Nations Children\u2019s Fund (UNICEF). WHO\/UNICEF estimates of national immunization coverage (Internet). Geneva: WHO; 2025 (cited 2025 Oct 23). Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/global-monitoring\/immunization-coverage\/who-unicef-estimates-of-national-immunization-coverage"},{"key":"ref16","unstructured":"World Health Organization (WHO). Measles cases surge worldwide, infecting 10.3 million people in 2023 (Internet). Geneva: WHO; 2024 (cited 2025 Nov 3). Available from: https:\/\/www.who.int\/news\/item\/14-11-2024-measles-cases-surge-worldwide--in\u00adfecting-10.3-million-people-in-2023"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Novilla MLB, Goates MC, Redelfs AH, Quenzer M, Novilla LKB, Leffler T, et al. Why parents say no to having their children vaccinated against measles: a systematic review of the social determinants of parental perceptions on MMR vaccine hesitancy. Vaccines. 2023 May 2;11(5):926. https:\/\/doi.org\/10.3390\/vaccines11050926","DOI":"10.3390\/vaccines11050926"},{"key":"ref18","unstructured":"World Health Organization (WHO). Measles and rubella strategic framework 2021\u20132030. Geneva: WHO; 2020. Available from: iris.who.int\/server\/api\/core\/bitstreams\/35644408-a362-4dc1-8368-4873c0d0833b\/content"},{"key":"ref19","unstructured":"Pan American Health Organization (PAHO). Regional immunization action plan for the Americas 2030. Washington, DC: PAHO; 2024. Available from: https:\/\/www.paho.org\/en\/documents\/regional-immunization-action-plan-americas-2030"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Mmanga K, Mwenyenkulu TE, Nkoka O, Ntenda PAM. Tracking immunization coverage, dropout and equity gaps among children ages 12\u201323 months in Malawi \u2013 bottleneck analysis of the Malawi Demographic and Health Survey. Int Health. 2021 Jun 21;14(3):250\u20139. https:\/\/doi.org\/10.1093\/inthealth\/ihab038","DOI":"10.1093\/inthealth\/ihab038"},{"key":"ref21","unstructured":"World Health Organization (WHO). Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake. Geneva: WHO; 2022. Available from: https:\/\/iris.who.int\/handle\/10665\/354459"},{"key":"ref22","unstructured":"World Health Organization (WHO). WHO recommendations on home-based records for maternal, newborn and child health. Geneva: WHO; 2018. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550352"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstreams\/0703d70f-5015-4dd6-b601-796005672b98\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:49:28Z","timestamp":1784036968000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/71692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":22,"alternative-id":["RPSP.2026.49"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2026.49","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}